marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 10-31-2024
Agios Pharmaceuticals Cash Flow 2011-2024 | AGIO
Annual Cash Flow Agios Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-296 M | -309 M | -407 M | -291 M | -371 M | -304 M | -285 M | 38.6 M | -76.9 M | - | -56.4 M | -49.5 M | -15.2 M |
Depreciation & Amortization |
6.6 M | 8.4 M | 8.8 M | 9.4 M | 8.09 M | 7.17 M | 6.43 M | 5.71 M | 3.34 M | 1.37 M | 1.44 M | 1.18 M | 801 K |
Accounts Payables |
9.78 M | 18.6 M | 16.7 M | 26.8 M | 21.9 M | 17.9 M | 22.8 M | 17.1 M | 14.7 M | 11.1 M | 3.68 M | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | 3.43 M | 3.37 M | - | - | - | - |
Total Inventories |
19.1 M | 8.49 M | - | - | 7.33 M | 869 K | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Agios Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -99.9 M | - | - | - | -95.2 M | - | -243 M | - | -97.7 M | - | -323 M | - | -121 M | - | -241 M | -173 M | -105 M | - | -277 M | -191 M | -103 M | - | -230 M | -166 M | -99 M | - | -211 M | -133 M | -74.1 M | - | 89.8 M | 139 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -37.9 M | -26.5 M | - | - | - | - | - |
Depreciation & Amortization |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.47 M | - | - | 4.04 M | 2 M | - | 5.26 M | 3.46 M | 1.72 M | - | 4.78 M | 3.16 M | 1.59 M | - | 3.99 M | 2.55 M | 1.25 M | - | 2.2 M | 1.15 M | 370 K | - | 1 M | 659 K | 332 K | - | 1.1 M | 723 K | 349 K | - | 856 K | 537 K | - | - | - | - | - |
Accounts Payables |
17.1 M | 10 M | 11.2 M | 9.78 M | 13.3 M | 11.6 M | 8.66 M | 18.6 M | 10.4 M | - | 11.6 M | 16.7 M | 10.3 M | 7.65 M | 51.2 M | 17.7 M | 17.7 M | 17.7 M | 17.7 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 17.9 M | 17.9 M | 17.9 M | 17.9 M | 22.8 M | 22.8 M | 22.8 M | 22.8 M | 17.1 M | 17.1 M | 17.1 M | 17.1 M | 14.7 M | 14.7 M | 14.7 M | 14.7 M | 11.1 M | 11.1 M | 11.1 M | 11.1 M | 3.68 M | 3.68 M | 3.68 M | 3.68 M | 3.31 M | 3.31 M | 3.31 M | - | - | - | - | - |
Accounts Receivables |
- | - | - | - | - | - | - | - | - | - | - | 4.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 169 K | 859 K | 779 K | 3.45 M | 3.43 M | 3.43 M | 3.43 M | 3.43 M | 3.37 M | 3.37 M | 3.37 M | 3.37 M | 2.33 M | 2.33 M | 2.33 M | 2.33 M | - | - | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
26.4 M | 23.9 M | 23.1 M | 19.1 M | 17.3 M | 15.7 M | 11.4 M | 8.49 M | 5.18 M | - | 2.48 M | - | - | - | - | 14.7 M | 11.4 M | 11.2 M | 9.78 M | 7.33 M | 7.33 M | 7.33 M | 7.33 M | 869 K | 869 K | 869 K | 869 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency